Listeria Monocytogenes Clinical Trial
Official title:
Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy: a Case Report and Review of Literatures
| NCT number | NCT03248973 |
| Other study ID # | 106030-C |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | April 3, 2017 |
| Est. completion date | February 2, 2018 |
| Verified date | February 2019 |
| Source | Far Eastern Memorial Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy
| Status | Completed |
| Enrollment | 1 |
| Est. completion date | February 2, 2018 |
| Est. primary completion date | January 8, 2018 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years and older |
| Eligibility |
Inclusion Criteria: - One pregnant woman with listeria monocytogenes bacteremia in the first trimester |
| Country | Name | City | State |
|---|---|---|---|
| Taiwan | Far Eastern Memorial Hospital | New Taipei |
| Lead Sponsor | Collaborator |
|---|---|
| Far Eastern Memorial Hospital |
Taiwan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Successful treatment | A favorable outcome of maternal listeria infection in the first trimester may be anticipated. Besides, intravenous ampicillin with or without gentamicin should be a reasonable treatment option for maternal listeria infection in the first trimester. | 1 month after delivery |